8 Responses

  1. bonny damocles
    bonny damocles September 10, 2012 at 12:31 pm | | Reply

    Dr. Jerry Colca’s 0602 mTOT Modulator is a very good idea. We hope that it becomes a reality sooner than later.

    I was already 55 years old when I was diagnosed as a type 2 diabetic in July 1991. At this late age, I asked myself, How many more good years do I have left considering that my diagnosis fasting blood sugar reading was a sky-high 468 mg/dl and for this very discouraging news, I had to take several anti-diabetes pills? The next question I asked myself was, How were other type 2′s who were on anti-diabetes pills doing? Based on the answers I got, I made the decision that I would not use any pharma drug. Instead, I would exercise as much as I could and would eat only heart-healthy, natural, fresh (raw or cooked), and unprocessed foods. Long story short, going 22 years as a t2d using daily exercise as my only anti-diabetes med, I have been living like I have no diabetes. I have never had any hypo episode, have never had any diabetes complications, and have had excellent A1c’s: from 5.2% to 6.3%.

    Bonny Damocles
    Male, 76 years old, 5’7″ tall, 141 lbs.’

  2. Joe
    Joe September 11, 2012 at 3:49 am | | Reply

    I’m a type 2, before I was on Insulin I was on Avandia. That particular medication gave me nothing but severely swollen ankles. I had my Dr. take me off of it.
    I’m so thankful to be on Insulin and Bydureon(the long acting version of Byetta) and have a hba1c of 6.1 .

  3. Metabolic Solutions Development Co. of Kalamazoo publishes break-through … | علاج مرض السكري

    [...] Metabolic Solutions has dual compounds in a new category of insulin sensitizers deliberate mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as intensity game-changers in diabetes treatment. [...]

  4. Metabolic Solutions Development Co. of Kalamazoo publishes break-through … | Today Health Channel

    [...] Metabolic Solutions has two compounds in a new class of insulin sensitizers considered mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as potential game-changers in diabetes treatment. [...]

  5. Metabolic Solutions Development Co. of Kalamazoo publishes break-through … | Diabetes treatment

    [...] Metabolic Solutions has dual compounds in a new category of insulin sensitizers deliberate mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as intensity game-changers in diabetes treatment. [...]

  6. New Launch MI Lab and other Kalamazoo operations playing roles in diabetes … | علاج مرض السكري

    [...] The drug target, called mTOT (for mitochondrial aim of thiazolidinediones), is a mobile protein formidable by that new anti-diabetic drugs can strive their insulin-sensitizing effects. The association has been building dual compounds deliberate mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as intensity game-changers in diabetes treatment. [...]

  7. New Launch MI Lab and other Kalamazoo operations playing roles in diabetes … | Today Health Channel

    [...] The drug target, called mTOT (for mitochondrial target of thiazolidinediones), is a cellular protein complex through which new anti-diabetic drugs can exert their insulin-sensitizing effects. The company has been developing two compounds considered mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as potential game-changers in diabetes treatment. [...]

  8. Diabetes treatment علاج السكري

    [...] The drug target, called mTOT (for mitochondrial aim of thiazolidinediones), is a mobile protein formidable by that new anti-diabetic drugs can strive their insulin-sensitizing effects. The association has been building dual compounds deliberate mTOT Modulators. They are dubbed MSDC-0160 and MSDC-0602 and have been talked about as intensity game-changers in diabetes treatment. [...]

Leave a Reply